Dongseong Rosuvastatin Tablets 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium
Prescription medication
Dongseong Pharmaceutical Co., Ltd.
MFDS item code 201803164 · Approved 2018.07.31
This product's status changed to Expired on 2023.07.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of dyslipidemia; prevention of cardiovascular diseases; inhibition of atherosclerosis progression
This medication is primarily helpful for patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise are insufficient. It is particularly used as an adjunct to diet or other treatments in patients with familial hypercholesterolemia, lowering total cholesterol and LDL cholesterol levels, thereby delaying the progression of atherosclerosis. It can also be used as an adjunct in dietary treatment for pediatric patients aged 10 to 17 who have high cholesterol levels. It is effective in patients with primary dysbetalipoproteinemia as well. Moreover, in adult patients at high risk for cardiovascular diseases, it helps reduce the risks of stroke, myocardial infarction, and arterial revascularization. Therefore, this medication is used for reducing the risk of hypercholesterolemia and cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted as the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients : Dose adjustment is not required. 4. Patients with renal impairment : No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administering doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients who are allergic to this drug, have severely impaired liver function, have muscle disorders, have severe renal impairment, or are pregnant or breastfeeding should avoid its use. Additionally, the risk of muscle-related side effects may increase when used with certain medications, so caution is needed when administering it concurrently. Patients who consume excessive alcohol or have a history of liver disease should undergo liver function tests before starting this medication and should have regular checks during treatment. If symptoms such as muscle pain or weakness occur, the doctor should be notified immediately, and blood tests should be performed to check for muscle damage if necessary. This medication contains lactose and is not suitable for patients with lactose intolerance. High doses may affect renal function; therefore, renal function tests are recommended for patients on high doses. If severe skin reactions or allergy symptoms occur during treatment, the medication should be stopped immediately, and a healthcare provider should be consulted. Women who could become pregnant should use appropriate contraceptive methods and should not use this medication during pregnancy. There is no specific antidote for overdose, so treatment should be symptomatic, and liver and muscle function tests are necessary. This medication may cause dizziness, so caution is advised when driving or operating machinery. Lastly, the effectiveness and side effects of this medication may vary according to certain genetic factors, and dose adjustments may be required based on the patient's condition.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to store it at room temperature between 1 to 30 degrees Celsius.
Pink round film-coated tablets
30 tablets (15 tablets/PTP(AluAlu)*2), 30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium
Prescription medication
Dongseong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.